Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
Q. Wang, S. Anang, S. Iketani, Y. Guo, L. Liu, D. D. Ho, J. G. Sodroski
Abstract
The recently emerged B.1.1.529 (Omicron) SARS-CoV-2 variant has a highly divergent spike (S) glycoprotein. We compared the functional properties of B.1.1.529 S with those of previous globally prevalent SARS-CoV-2 variants, D614G and B.1.617.2. Relative to these variants, B.1.1.529 S exhibits decreased processing, resulting in less efficient syncytium formation and lower S incorporation into virus particles. Nonetheless, B.1.1.529 S supports virus infection equivalently. B.1.1.529 and B.1.617.2 S glycoproteins bind ACE2 with higher affinity than D614G S. The unliganded B.1.1.529 S trimer is less stable at low temperatures than the other SARS-CoV-2 spikes, a property related to spike conformation. Upon ACE2 binding, the B.1.1.529 S trimer sheds S1 at 37 degrees but not at 0 degrees C. B.1.1.529 pseudoviruses are relatively resistant to neutralization by sera from convalescent COVID-19 patients and vaccinees. These properties of the B.1.1.529 spike glycoprotein likely influence the transmission, cytopathic effects and immune evasion of this emerging variant.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission
Mehdi Benlarbi, Shilei Ding, … Andrés Finzi·mBioPeer-reviewed·Jul 2, 2024
- Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
L. Yurkovetskiy, X. Wang, … J. Luban·bioRxiv·Jul 4, 2020
- D614G and Omicron SARS-CoV-2 variant spike proteins differ in the effects of N-glycan modifications on spike expression, virus infectivity, and neutralization by some therapeutic antibodies
S. Lusvarghi, C. B. Stauft, … C. D. Weiss·bioRxiv·May 10, 2023
- Determinants of Spike Infectivity, Processing and Neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2
C. Pastorio, F. Zech, … F. Kirchhoff·bioRxiv·Apr 13, 2022
- Uncovering the structural flexibility of SARS-CoV-2 glycoprotein spike variants
H. R. S. Arruda, T. M. Lima, … G. A. P. de Oliveira·bioRxiv·Apr 20, 2022
- Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants